Piper Sandler analyst Edward Tenthoff raised the firm’s price target on Mesoblast (MESO) to $24 from $15 and keeps an Overweight rating on the ...

Ossium Health, a clinical-stage bioengineering company with a first-of-its-kind bone marrow banking platform for processing ...

Cells navigating in complex microenvironments frequently encounter narrow spaces that physically challenge migration.

Inflammatory bowel diseases (IBDs), which include ulcerative colitis (UC) and Crohn’s disease (CD), are chronic conditions ...

Fresh from FDA approval for its paediatric stem-cell product, Mesoblast is pursuing consent for indications of heart disease ...

The Mesoblast Ltd (ASX: MSB) share price is charging higher today. Again. Shares in the S&P/ASX 300 Index (ASX: XKO) ...

Mesoblast’s RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA-approved mesenchymal ...

One product I now rely on to keep dryness, tightness, and those pesky lines at bay is the Guerlain Abeille Royale Youth ...

Eating foods high in key nutrients, including iron, folic acid, and vitamin B12, and limiting alcohol may help increase your red blood cell count. Red blood cells are the most common cells in ...

Mesenchymal stem cells (MSC) offer immense potential in upgrading treatments for serious medical conditions. Credit: via Shutterstock. As cell and gene therapies become more prevalent, the need for ...

In 2009 a team of biophysicists led by Anthony A. Hyman of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany, were studying specklelike structures called P ...